Back

Multi-level thromboinflammatory activation after TAVR: systemic, cellular, and platelet transcriptomic changes

29 August 2026 (08:15 - 08:45)
Organised by: Logo
Congress Presentation Part of: Beyond the valve and vessel: systemic risk, inflammation, and complex interventions Aortic Valve Intervention ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Doctor David Hesselbarth

University Heart Center Freiburg-Bad Krozingen, Freiburg (Germany)

4 More presentations in this session

Presentation thumbnail
Culprit-only versus multivessel percutaneous coronary intervention in acute myocardial infarction complicated by cardiogenic shock: an updated systematic review and meta-analysis
Doctor V. Gomez Lopez (Mexico City, MX)
Abstract
Presentation thumbnail
Prognostic value of TAPSE/sPAP ratio across cardiovascular–kidney–metabolic phenotypes after TAVI
Doctor K. Hu (Wuerzburg, DE)
Abstract
Presentation thumbnail
Systemic atherosclerosis assessment using lipoprotein(a) and angioscopy: a prospective study of cholesterol crystal detection
Doctor Y. Tanaka (Tokyo, JP)
Abstract
Presentation thumbnail
Safety and efficacy of intravascular lithotripsy-facilitated transcatheter aortic valve replacement: a systematic review and meta-analysis
Doctor D. Chekhava (Bronx, US)
Abstract

Access the full session

Session thumbnail
Beyond the valve and vessel: systemic risk, inflammation, and complex interventions

The Event

Event poster

ESC Congress 2026

29 August 2026 08:15 CET
You may be interested in
thumbnail
Congress Presentation
Whole-blood transcriptome unveils altered immune response in acute myocardial infarction patients with aortic valve sclerosis
12 April 2024
thumbnail
Congress Presentation
Thrombin generation and platelet function in patients on RAAS inhibitors
2 September 2019
thumbnail
Congress Presentation
Inflammatory thrombosis is a denominator of permanent platelet activation in chronic thromboembolic pulmonary hypertension
1 September 2025
thumbnail
Congress Presentation
Predictors of bleeding complications during hospitalization in patients with atrial fibrillation who underwent transcatheter aortic valve replacement
29 June 2021

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources